These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9062685

  • 1. No. 302, a newly synthesized [pGlu4,Cyt6]AVP(4-9) analogue, prevents the disruption of avoidance behavior.
    Hirate K, Hirano M, Nakajima Y, Hiyama A, Maeda O, Asakura W.
    Behav Brain Res; 1997 Feb; 83(1-2):205-8. PubMed ID: 9062685
    [Abstract] [Full Text] [Related]

  • 2. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    de Wied D, Gaffori O, Burbach JP, Kovács GL, van Ree JM.
    J Pharmacol Exp Ther; 1987 Apr; 241(1):268-74. PubMed ID: 3572787
    [Abstract] [Full Text] [Related]

  • 3. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
    de Wied D, Elands J, Kovács G.
    Proc Natl Acad Sci U S A; 1991 Feb 15; 88(4):1494-8. PubMed ID: 1847526
    [Abstract] [Full Text] [Related]

  • 4. Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze.
    Mishima K, Tsukikawa H, Miura I, Inada K, Abe K, Matsumoto Y, Egashira N, Iwasaki K, Fujiwara M.
    Neuropharmacology; 2003 Mar 15; 44(4):541-52. PubMed ID: 12646291
    [Abstract] [Full Text] [Related]

  • 5. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures.
    Kovács GL, Veldhuis HD, Versteeg DH, De Wied D.
    Brain Res; 1986 Apr 16; 371(1):17-24. PubMed ID: 3708341
    [Abstract] [Full Text] [Related]

  • 6. Vasopressin anti-idiotypic antibody staining in the rat brain: colocalization with [35S] [pGlu4, Cyt6]AVP(4-9) binding sites.
    Jurzak M, Fahrenholz F, Gerstberger R.
    J Neuroendocrinol; 1993 Oct 16; 5(5):523-31. PubMed ID: 8680420
    [Abstract] [Full Text] [Related]

  • 7. Formation of metabolites of [Arg8]vasopressin (AVP) by brain peptidases. Conversion of the intermediate [Cyt6]AVP-(3-9).
    Wang XC, Burbach JP.
    FEBS Lett; 1986 Mar 03; 197(1-2):164-8. PubMed ID: 3949012
    [Abstract] [Full Text] [Related]

  • 8. Long-term facilitation of social recognition in rats by vasopressin related peptides: a structure-activity study.
    Popik P, Van Ree JM.
    Life Sci; 1992 Mar 03; 50(8):567-72. PubMed ID: 1736027
    [Abstract] [Full Text] [Related]

  • 9. Cysteinyl methyl ester of AVP(4-8), a potent agonist on the maintenance of passive avoidance in rats.
    Lin C, Liu RY, Du YC.
    Peptides; 1990 Mar 03; 11(4):633-9. PubMed ID: 2235674
    [Abstract] [Full Text] [Related]

  • 10. NC-1900, a [pGlu4,Cyt6]AVP(4-9) analogue, facilitates the learning performance of rats on delayed nonmatching to sample task in Y-water maze.
    Hirano M, Hirate K, Miyake N.
    Methods Find Exp Clin Pharmacol; 1998 Sep 03; 20(7):567-73. PubMed ID: 9819800
    [Abstract] [Full Text] [Related]

  • 11. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
    De Wied D, Gaffori O, Van Ree JM, De Jong W.
    Pharmacol Biochem Behav; 1984 Sep 03; 21(3):393-400. PubMed ID: 6093152
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vasopressin neuropeptides and acquisition of heroin and cocaine self-administration in rats.
    van Ree JM, Burbach-Bloemarts EM, Wallace M.
    Life Sci; 1988 Sep 03; 42(10):1091-9. PubMed ID: 3347140
    [Abstract] [Full Text] [Related]

  • 19. Effect of vasopressin, oxytocin and peptides derived from these hormones on field potential induced in lateral septum of rats by stimulation of the fimbria fornix.
    Urban IJ, De Wied D.
    Neuropeptides; 1986 Jan 03; 7(1):41-9. PubMed ID: 3951680
    [Abstract] [Full Text] [Related]

  • 20. Characterization of binding sites of a memory-enhancing peptide AVP(4-8) in rat cortical synaptosomal membranes.
    Du YC, Wu JH, Jiang XM, Gu YJ.
    Peptides; 1994 Jan 03; 15(7):1273-9. PubMed ID: 7854980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.